Question from Deputy Ken O'Flynn - PQ 15882-26

To ask the Minister for Health whether formal commercial negotiations between the HSE Corporate Pharmaceutical Unit and the relevant marketing authorisation holders in respect of tirzepatide and semaglutide are currently active; whether any price proposal has been received following completion of the HTA processes; whether any budget ceiling or access cap has been set as a matter of Departmental policy; and if she will make a statement on the matter.